Samsara Bio Capital, LLC Kala Pharmaceuticals, Inc. Transaction History

Samsara Bio Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$3.67 - $38.15 $2.16 Million - $22.5 Million	-589,138 Reduced 98.0%	12,024 $458,000
Q4 2020 Feb 17, 2021	BUY	$6.28 - $8.79 $942,000 - $1.32 Million	150,000 Added 33.25%	601,162 $4.08 Million
Q3 2020 Nov 16, 2020	BUY	$7.5 - $11.11 $840,450 - $1.24 Million	112,060 Added 33.05%	451,162 $3.38 Million
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $2.29 Million - $3.79 Million	275,000 Added 429.0%	339,102 $3.56 Million
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $245,510 - $563,456	64,102 New	64,102 $563,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.